5 @aminolevulinate synthase erythroid specific; 5 aminolevulinate synthase 2; 5 aminolevulinate synthase 5 aminolevulinate synthase 2; 5 aminolevulinate synthase erythroid specific mitochondrial; 5 aminolevulinic acid synthase 2; 5 aminolevulinic acid synthase; 5-aminolevulinate synthase; 5-aminolevulinic acid synthase 2; Alas 2; ALAS; ALAS E; ALAS; erythroid; ALAS-E; Alas2; ALASE; Aminolevulinate delta synthase 2; Aminolevulinic acid synthase 2; erythroid; ANH1; ASB; Delta ALA synthase 2; Delta ALA synthetase; Delta aminolevulinate synthase 2; Delta aminolevulinate synthase; Delta-ALA synthase 2; Delta-aminolevulinate synthase 2; Erythroid specific ALAS; erythroid-specific; FLJ93603; HEM0_HUMAN; mitochondrial; OTTHUMP00000023388; OTTHUMP00000023389; OTTMUSP00000020679; RP23-338A17.1; SIDBA1; XLDPP; XLEPP; XLSA
Source
Recombinant protein corresponding to aa50-587 from human 5-aminolevulinate synthase, erythroid-specific, fused to 6X His-Tag at N-terminal, expressed in E.coli.
Amino Acid Sequence
QIHLKATKAGGDSPSWAKGHCPFMLSELQDGKSKIVQKAAPEVQEDVKAFKTDLPSSLVSVSLRKPFSGPQEQEQISGKVTHLIQNNMPGNYVFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGAGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA
Storage and Stability
Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Source
Recombinant, E. coli
Form
Supplied as a lyophilized powder from 20mM Tris-HCl, 0.5M sodium chloride, pH 8.0, 6% trehalose. Reconstitute with sterile ddH2O to a concentration of 0.1-1mg/ml.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a lyophilized powder from 20mM Tris-HCl, 0.5M sodium chloride, pH 8.0, 6% trehalose. Reconstitute with sterile ddH2O to a concentration of 0.1-1mg/ml.
TDS
NCBI
UniProt
Tech Support
Customer Service
